Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis : The GENOMOS study

Abstract Introduction The TGFB1 gene which encodes transforming growth factor beta 1, is a strong candidate for susceptibility to osteoporosis and several studies have reported associations between bone mineral density (BMD), osteoporotic fractures and polymorphisms of TGFB1 , although these studies have yielded conflicting results. Methods We investigated associations between TGFB1 polymorphisms and BMD and fracture in the GENOMOS study: a prospective multicenter study involving 10 European research studies including a total of 28,924 participants. Genotyping was conducted for known TGFB1 polymorphisms at the following sites: G − 1639 -A (G − 800 -A, rs1800468), C − 1348 -T (C − 509 -T, rs1800469), T 29 -C (Leu10Pro, rs1982073), G 74 -C (Arg25Pro, rs1800471) and C 788 -T (Thr263Ile, rs1800472). These polymorphisms were genotyped prospectively and methodology was standardized across research centers. Genotypes and haplotypes were related to BMD at the lumbar sine and femoral neck and fractures. Results There were no significant differences in either women or men at either skeletal site for any of the examined polymorphisms with the possible exception of a weak association with reduced BMD (− 12 mg/cm 2 ) in men with the T − 1348 allele ( p 788 allele was 1.64 (95% CI: 1.09–2.64), p Conclusions This study indicates that polymorphic variation in the TGFB1 gene does not play a major role in regulating BMD or susceptibility to fractures. The weak associations we observed between the C − 1348 -T and lumbar spine BMD in men and between C 788 -T and risk of incident vertebral fractures are of interest but could be chance findings and will need replication in future studies.